Decreases in heart rate variability, a marker of autonomic nervous system function, are associated with increased cardiovascular mortality. Heart rate variability increases in non-rapid eye movement sleep, peaking in slow-wave sleep. Therefore, decreasing the amount of deep sleep, for example, by introducing patients to a sleep laboratory environment, could decrease heart rate variability, increasing cardiovascular risk. We studied four groups of women with no previous sleep laboratory experience: young [n = 11, 23.1 (0.5) years]; perimenopausal [n = 15, 48.0 (0.4) years]; postmenopausal without hormone therapy [n = 22, 63.4 (0.8) years]; and postmenopausal on hormone therapy [n = 16, 63.1 (0.9) years], using a cross-sectional design. Polysomnography including electrocardiogram was performed over two consecutive nights. Heart rate variability was assessed overnight, and the first-night effect on heart rate variability was analysed. Furthermore, correlations between heart rate variability and sleep variables were analysed. Using combined groups, only minor changes were observed in non-linear heart rate variability, indicating increased parasympathetic tone from the first to the second night. No group differences in first-night effect were seen. Heart rate variability and sleep variables were not significantly correlated. Heart rate variability decreased with increasing age, and it was lowest in the postmenopausal women on hormone therapy. We conclude that a first night in a sleep laboratory elicits only minimal changes in overnight vagally mediated non-linear heart rate variability in women irrespective of reproductive state. This finding warrants further analyses in different sleep stages, but suggests that changes in sleep architecture per se do not predict the autonomic strain of a poor night.
Decreases in heart rate variability, a marker of autonomic nervous system function, are associated with increased cardiovascular mortality. Heart rate variability increases in non-rapid eye movement sleep, peaking in slow-wave sleep. Therefore, decreasing the amount of deep sleep, for example, by introducing patients to a sleep laboratory environment, could decrease heart rate variability, increasing cardiovascular risk. We studied four groups of women with no previous sleep laboratory experience: young [n = 11, 23.1 (0.5) years]; perimenopausal [n = 15, 48.0 (0.4) years]; postmenopausal without hormone therapy [n = 22, 63.4 (0.8 ) years]; and postmenopausal on hormone therapy [n = 16, 63.1 (0.9) years], using a cross-sectional design. Polysomnography including electrocardiogram was performed over two consecutive nights. Heart rate variability was assessed overnight, and the first-night effect on heart rate variability was analysed. Furthermore, correlations between heart rate variability and sleep variables were analysed. Using combined groups, only minor changes were observed in non-linear heart rate variability, indicating increased parasympathetic tone from the first to the second night. No group differences in first-night effect were seen. Heart rate variability and sleep variables were not significantly correlated. Heart rate variability decreased with increasing age, and it was lowest in the postmenopausal women on hormone therapy. We conclude that a first night in a sleep laboratory elicits only minimal changes in overnight vagally mediated non-linear heart rate variability in women irrespective of reproductive state. This finding warrants further analyses in different sleep stages, but suggests that changes in sleep architecture per se do not predict the autonomic strain of a poor night.
IN TROD UCTI ON
Heart rate variability (HRV), i.e. the multidimensional changes in heart rate in time (Task Force, 1996) , is mediated by the changes in the heart's autonomic innervation. Sympathetic output increases heart rate and decreases shortterm HRV (Task Force, 1996) , while high vagal output results in bradycardia and increased respiratory sinus arrhythmia (Task Force, 1996) . Several highly intercorrelated parameters based on both linear and non-linear mathematical methods are used to measure HRV (Task Force, 1996; Yeragani et al., 1998) . The evaluation of the triggers connected with decreased HRV is essential, as the risk of lethal and potentially lethal cardiovascular events and even overall mortality are increased with decreasing HRV (Huikuri and Stein, 2013) .
Heart rate variability is strongly modulated by sleep and further by various sleep stages. From wake to stable nonrapid eye movement (NREM) sleep, sympathetic activity decreases and vagal influence gradually increases, being at its highest in slow-wave sleep (SWS; Ako et al., 2003; Versace et al., 2003; Virtanen et al., 2007) . In rapid eye movement (REM) sleep, HRV closely resembles that seen awake, with rapid vagal to sympathetic fluctuations (Ako et al., 2003; Versace et al., 2003; Virtanen et al., 2007) . Sleep architecture is deteriorated in an unknown environment, with less SWS and more light sleep (the so-called 'firstnight effect'; Agnew et al., 1966) . Therefore, it can be assumed that during a first night in a sleep laboratory there is a decrease in parasympathetic and an increase in sympathetic activity. In young adults, selective SWS deprivation attenuates the nocturnal decrease in arterial blood pressure attributed to increased parasympathetic tone (Sayk et al., 2010) , and similar findings together with a higher nocturnal heart rate are seen in young adults with low sleep efficiency measured by actigraphy (Ross et al., 2014) . In selfreported insomnia, short-term HRV during light NREM sleep and REM sleep is decreased as compared with good sleepers, and sympathetic activity is increased during presleep wakefulness (Spiegelhalder et al., 2011; de Zambotti et al., 2014) .
In aging, overall and especially vagally mediated HRV is decreased both in women and in men (Laitinen et al., 1998; Vigo et al., 2005) . In premenopausal women, vagally mediated HRV indexes are higher than in same-age men but, after menopause, this favourable effect vanishes and both sexes show similar HRV (Huikuri et al., 1996; Ryan et al., 1994) . Changes in hormonal levels across the menstrual cycle influence autonomic function, with increased heart rate and decreased vagal function during progesterone peaks (de Zambotti et al., 2013b (de Zambotti et al., , 2017 . Further, menopausal hot flushes are associated with an increased heart rate and a decreased vagal tone (de Zambotti et al., 2013a) . In perimenopausal or recently postmenopausal women, hormone therapy (HT) used for climacteric symptom relief increases cardiac vagal output (G€ okce et al., 2005; Huikuri et al., 1996; Mercuro et al., 2000; Rosa Brito-Zurita et al., 2003; Rosano et al., 1997) . However, in women more than 10 years postmenopausal either no effect (Niskanen et al., 2002; Virtanen et al., 2000) or even a decrease in vagal activity and non-linear complexity of heart rate has been observed (Christ et al., 1999; Lantto et al., 2012; Virtanen et al., 2008) . Therefore, it can be assumed that HT may promote cardiovascular risk in older postmenopausal women (Christ et al., 1999; Grodstein et al., 2006; Hodis and Mack, 2014; Virtanen et al., 2008) .
Based on the above rationale, we set out to study nocturnal HRV during two consecutive nights in a sleep laboratory in study-na€ ıve young, perimenopausal and postmenopausal women. We have previously shown that during a first night in a sleep laboratory, sleep efficiency is lower and the amount of awakenings increased, but sleep is somewhat deeper as compared with the second night in the same population (Virtanen et al., 2016) . We hypothesized that during a first night in a sleep laboratory, an increased sympathetic and decreased vagal input to the heart should be observed. Further, we wanted to observe whether age, reproductive state or use of HT would modulate this response.
MAT ERIALS AN D METH ODS

Study participants
The study was part of a larger study analysing the effects of ageing, hormonal state and HT on sleep and cognition performed in the sleep research units of University of Turku, Finland and University of Helsinki, Finland. Perimenopausal and postmenopausal women were recruited from the Turku area through newspaper announcements, and young women by announcement at the University of Helsinki. The recruited group of women included 17 perimenopausal, 44 postmenopausal and 11 young women. Women were defined as perimenopausal if serum follicle-stimulating hormone (FSH) levels were lower than 23 IU L À1 and they had ongoing regular or irregular menstrual cycle, whereas postmenopausal women were defined by age over 57 years and chronic amenorrhoea of more than 1 year. Exclusion criteria screened in a pre-study 1.5-h personal interview by an experienced sleep-specialized physician consisted of existing cardiovascular (hypertension controlled with medication was accepted), pulmonary, neurological, endocrinological or mental disease, irregular or delayed sleep schedule, and specific sleep disorders, such as sleep apnea, narcolepsy or restless legs syndrome. Women suffering from conditions that could affect sleep, like fibromyalgia and anaemia, were excluded. Other exclusion criteria included the use of medication affecting the central nervous system, including sleeping pills, alcohol abuse, smoking and excessive caffeine intake (over 5 cups of coffee per day). Before the study, blood haemoglobin, leucocytes, thrombocytes and serum thyrotropin levels were measured and required to fall within normal ranges. None of the study subjects had sleep laboratory experience.
First-night effect on HRV in womenClimacteric symptomatology was scored before the first night with questions on the frequency of both night sweats and hot flushes during the last 6 months on a scale of 1 to 4 (1 = seldom or never; 2 = once a month; 3 = once a week; 4 =almost every day), giving a maximum score of 8 points. No group differences in symptom scores were observed (Table 1) . Mood disorders were excluded with the Beck Depression Inventory (Beck et al., 1961) . The women kept a sleep diary 3 weeks before and 1 week after the sleep studies to ensure a regular sleep-wake schedule required for inclusion (from 22:00-23:00 hours to 06:00-07:00 hours). The study protocol is described in detail in previous reports (Kalleinen et al., 2006 (Kalleinen et al., , 2008 Virtanen et al., 2016) .
Procedure
For serum FSH and estradiol (E 2 ) measurements, a blood sample was drawn in the morning following the first night to ensure appropriate use of HT. Height and weight were measured, and body mass index (kg m
À2
) was calculated accordingly. The Sleep Research Unit provided prearranged, nutritionally similar meals and caffeine-free coffee or tea served at specific times for the subjects during the study.
Polysomnography was performed over two consecutive nights from 23:00 hours to 07:00 hours, and scored by experienced scorers (N.K., P.P.-K. and I.V.) according to the Rechtschaffen and Kales criteria (Rechtschaffen and Kales, 1968) valid during data collection (2001) (2002) (2003) (2004) . The sleep data and first-night effect on sleep are described in detail in a previous report (Virtanen et al., 2016) . From pulse oximetry, the oxygen desaturation index (ODI4, saturation drop of 4% or more per hour) was estimated, and a mean of the ODI4 values from the two consecutive nights was calculated. ODI4 values were missing from one perimenopausal and one on-HT postmenopausal woman. Furthermore, three off-HT women and one on-HT woman had a mean ODI4 of 15 per h or more. However, excluding these women from the analyses did not change the results; therefore, their data were included in the present report.
Heart rate variability was assessed from a two-lead electrocardiogram from both nights using QRS complex detection by the WinCPRS â software (Absolute Aliens, Turku, Finland). Data sampling and analysis covered the full night between 23:00 hours and 07:00 hours for all parameters. All data were manually checked for artefacts and ectopic beats, and R-R detection was corrected when needed (I.V.). Single, sparse ectopic beats were not corrected, but where large amounts of ectopic beats were observed, the data were discarded from the final analysis. In time domain, the standard deviation of the R-R interval (SDNN), and two vagally mediated variables, the root mean square of successive R-R interval differences (RMSSD) and the percentage of the successive R-R intervals with over 50 ms difference in duration (pNN50) were measured (Task Force, 1996) .
In frequency domain, we calculated total 0-0.50 Hz, verylow-frequency (VLF) 0.003-0.04 Hz, low-frequency (LF) 0.04-0.15 Hz and high-frequency (HF) 0.15-0.40 Hz power bands (Task Force, 1996) . The VLF and HF bands are mostly products of vagally transmitted oscillations, but the LF band has a high sympathetic input. Therefore, the LF/HF ratio was calculated to estimate sympathovagal balance (Task Force, 1996) .
Non-linear variables calculated were the spectral power law (SPL) slope, spectral entropy (SEn), the short-and long-term R-R interval variability coefficients SD1 and SD2 from Poincar e plots, and the short-and intermediate-term scaling exponents a1 (4-11 beats) and a2 (>11 beats) using detrended fluctuation analysis (Seely and Macklem, 2004) . The SPL slope, also known as b, is the exponent of the observed 1/f b decay of R-R interval spectral power in the logarithmic scale, and it is used to measure the non-linear Table 1 Demographic information in study groups
Vasomotor symptom score
Beck depression inventory score
Young women (n = 10) 23.1 AE 0.5 22.4 AE 0.7** 3.5 AE 0.8** 0.08 AE 0.02 † 2.6 AE 0.3 1.5 AE 0.5** Perimenopausal women (n = 15) 48.0 AE 0.4 24.2 AE 0.6* 3.3 AE 0.7 11.4 AE 1.3** 0.33 AE 0.09** 2.6 AE 0.2 3.9 AE 0.8
Off-HT postmenopausal women (n = 22) 63.4 AE 0.8 27.4 AE 1.1 8.8 AE 2.3 † 78.9 AE 7.1 0.03 AE 0.00 3.7 AE 0.5 6.9 AE 0.9
On-HT postmenopausal women (n = 15) 63.1 AE 0.9 24.9 AE 0.6 7.2 AE 2.6 13.0 AE 3.8** 0.21 AE 0.03* 2.6 AE 0.3 4.2 AE 0.9 E 2 , estradiol; FSH, follicle-stimulating hormone; HT, hormone therapy; ODI4, oxygen desaturation index (saturation drop of 4% or more per hour). *P < 0.05 compared with off-HT postmenopausal women. **P < 0.01 compared with off-HT postmenopausal women. † P < 0.05 compared with perimenopausal women.
ª 2017 European Sleep Research Society complexity of heart rate (Goldberger and West, 1987) . The Poincar e plot method is a geometric method that provides a beat-to-beat visual and quantitative analysis of R-R intervals by plotting each R-R interval of a sinus beat as a function of the previous one (M€ akikallio et al., 2004) . Detrended fluctuation analysis characterizes fluctuations on scales of multiple lengths. Its scaling exponents a1 and a2 quantify the self-similarity in the amount of fluctuation in heart rate over short and long periods of time, respectively (Peng et al., 1995) . The Poincar e plot statistics and fractal dimension correlate with frequency domain HF power variability, which indicates that they are vagally modulated (Yeragani et al., 1998) .
Statistical analysis
Statistical analyses were made using the IBM SPSS â ver.
22.0 software. Data were tested for normality and observed to be highly skewed in different directions and, accordingly, non-parametric tests were used. Differences between the four groups (group effect) in HRV variables were analysed separately for night 1 and night 2 using the independent samples Kruskall-Wallis test. For post hoc analyses between groups, Mann-Whitney U-test with Bonferroni correction was used. The first-night effect (time effect) was analysed in both groups combined, and group-wise, using the Wilcoxon signed rank test. The Group 9Time interaction, i.e. group differences in the between-nights difference, were again analysed using the independent samples Kruskall-Wallis test, and Mann-Whitney U-test with Bonferroni correction for post hoc analyses. Correlations between HRV and sleep variables were analysed separately during both nights using non-linear Spearman's correlation analysis. For this analysis, combined groups were used because group sizes were too small for group-wise correlation analyses, but age-adjusted correlations were calculated due to large differences in HRV parameters between groups. All results are mean (SEM). P-values of <0.05 were considered significant.
Ethics
The study was approved by the Ethical Committees of Turku University Central Hospital and University of Helsinki. All study participants gave written informed consent after oral and written information of the study.
RESUL TS Group differences, night 1
During the first night, young women had higher RMSSD, pNN50, HF power and SD1 than any other group. Compared with perimenopausal women, young women also had lower a1 and LF/HF ratio. Furthermore, compared with the off-HT and on-HT groups, young women had higher values of SDNN, total, VLF and LF powers and SD2. The perimenopausal group had higher LF power than either of the postmenopausal groups, and higher LF/HF ratio than off-HT postmenopausal women. There were no differences between the postmenopausal groups (Table 2 ).
Group differences, night 2
During the second night, young women had higher RMSSD, total and HF powers, SD1 and SD2 than the other groups. Compared with perimenopausal women, young women also had lower a1 and LF/HF ratio. Compared with the postmenopausal groups, young women had higher SDNN, pNN50, VLF and LF powers and SEn. SEn was higher in the perimenopausal than the postmenopausal off-HT group. Further, perimenopausal women had lower maximum heart rate, higher SDNN, total, VLF and LF powers, and SD2 than on-HT postmenopausal women. Off-HT postmenopausal women had higher SDNN, total power and SD2 than on-HT postmenopausal women (Table 2) .
First-night effect
Between nights, when groups were combined, there were only few changes in non-linear HRV and none in linear HRV. The SPL slope decreased from 0.960 (0.039) to 0.894 (0.036) (P = 0.029) between the first and second nights, and SEn increased from 0.767 (0.008) to 0.781 (0.009) (P = 0.037). In group-wise analysis, the only difference between nights was seen in the postmenopausal on-HT group where a1 increased from 0.994 (0.077) to 1.075 (0.065) (P = 0.006) between nights (Figs 1 and 2 ; Table 2 ). 
First-night effect on HRV in womenGroup 3 Time interaction
No between-group differences in the first-night effect were observed in any of the variables (Table 2) .
Sleep versus HRV, night 1
In the age-adjusted correlation analysis, more S1 sleep and a higher awakening index were associated with a higher a1. No other correlations were observed (Table 3) .
Sleep versus HRV, night 2
During the second night, more S1 and S2 sleep were associated with a higher SEn. A higher sleep efficiency correlated with a lower SD2, and more wake time was associated with higher SDNN and SD2. A longer S2 sleep latency correlated with a lower mean heart rate and a longer REM latency with a higher HF power. Further, a higher percentage of REM sleep increased a1 (Table 3) .
DISCUSSION
To our knowledge, this is the first time that the possible effects of a first night's sleep on HRV in different female reproductive states have been evaluated. While time domain HRV, frequency domain power bands, SEn and the Poincar e plot variables were lower during peri-and postmenopause, and LF/HF ratio and a1 was higher in the perimenopause, HT influenced HRV only marginally, and the reproductive state did not affect the first-night effect on HRV. From the first to the second night, only a small decrease in the SPL slope and a likewise small increase in SEn were observed in the entire study population, indicating a slightly increased parasympathetic activation on the second night. In the subgroup analyses, the only observed between-night difference was ª 2017 European Sleep Research Society a slight increase in a1 on the second night in the postmenopausal on-HT women, actually indicating lower parasympathetic tone. When adjusting for age, some associations between sleep parameters and non-parametric HRV were seen during both nights, but the correlations were rather weak and inconsistent.
The minor difference observed in HRV was quite intriguing, given that in our previous analysis on this population, marked differences between first and second nights in sleep parameters were observed in all reproductive groups. These changes included increases in sleep efficiency, S1 and S2 sleep, and decreases in wake after sleep onset, awakenings and SWS during the second night (Virtanen et al., 2016) . Previously, after a total 40-h sleep deprivation (Virtanen et al., 2015) , we detected a significant change in both linear and non-linear HRV during a recovery night as compared with the pre-sleep deprivation night. Prior literature shows an increase of vagal tone from wake to NREM sleep and wakelike HRV in REM sleep during undisturbed sleep (Ako et al., 2003; Versace et al., 2003; Virtanen et al., 2007) . However, HF, high-frequency; HT, hormone therapy; LF, low-frequency; pNN50, percentage of the successive R-R intervals with over 50 ms difference in duration; RMSSD, root mean square of successive R-R intervals; SD1, short-term R-R interval variability coefficient; SD2, long-term R-R interval variability coefficient; SDNN, standard deviation of R-R intervals; SEn, spectral entropy; SPL, spectral power law; VLF, very-lowfrequency. Parasympathethic = indexes increasing with increasing parasympathetic tone; Sympathetic = indexes increasing with increasing sympathetic or decreasing parasympathetic tone. *P < 0.05 compared with young women. **P < 0.01 compared with young women. † P < 0.05 compared with perimenopausal women. † † P < 0.01 compared with perimenopausal women. § P < 0.05 compared with off-HT postmenopausal women. ¶ P < 0.01 between nights.
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First-night effect on HRV in womendata on the first-night effect on HRV are virtually non-existent. In young adults, selective SWS deprivation increases nocturnal arterial blood pressure (Sayk et al., 2010) , and low sleep efficiency increases nocturnal heart rate (Ross et al., 2014) . Furthermore, insomnia is associated with decreased time domain HRV (Spiegelhalder et al., 2011) . These results imply that sleep disturbance decreases parasympathetic tone. Although not directly comparable, these studies may give a hint as to why our HRV findings were so negligible. It is possible that while wake time decreased and thus sleep efficiency increased at the second night in our subjects (increasing sleep quantity), simultaneously decreasing SWS and increasing S1 sleep (worse sleep quality) pulled the overnight vagal gain back towards zero. HRV in separate sleep stages might have looked different. We, however, opted for an all-night analysis due to limitations of the mathematical paradigms. The Poincar e plot variables and a2 require lengthy time periods for reliability (Task Force, 1996; Seely and Macklem, 2004) and, for example, SDNN needs time sections of exactly identical lengths to be comparable between epochs (Task Force, 1996) . As many women had only short epochs of wake and stage 1 sleep, they could not have been reliably compared with other sleep stages.
We confirmed previous findings that HRV decreases with aging (Laitinen et al., 1998; Vigo et al., 2005) . Our focus was in women, particularly on the hormonal changes after menopause. Postmenopausal women and same-age men show similar HRV (Ryan et al., 1994) , while premenopausal middle-aged women sport higher vagal HRV indexes than men of the same age (Huikuri et al., 1996; Ryan et al., 1994) .
The SPL slope, entropy, and a1 and a2 show a cut-off point at 50 years old, after which a sharp increase in a2 and a concomitant decrease in the other variables is observed regardless of gender (Vandeput et al., 2012) . The age regression in non-linear HRV variables is stronger in women than in men (Vandeput et al., 2012) . These differences in gender-specific trajectories indicate that menopause has a significant, age-independent effect on HRV. The HRV differences in our study are similar to previous reports, although the exact values differ between studies (Laitinen et al., 1998; Vigo et al., 2005) . The difference can be accounted for previous studies having gender-mixed populations in comparison to our all-female cohort.
Postmenopausal HT is cardioprotective, especially when initiated less than 10 years after menopause (Grodstein et al., 2006; Hodis and Mack, 2014; Stevenson, 2009 ). In our study, the postmenopausal women, especially those using HT, had overall the lowest HRV, particularly when the parasympathetic variables were concerned. In younger perimenopausal or recently postmenopausal women, linear HRV increases and LF/HF ratio decreases during HT (G€ okce et al., 2005; Huikuri et al., 1996; Mercuro et al., 2000; Rosa Brito-Zurita et al., 2003; Rosano et al., 1997) , but in older postmenopausal populations, there is either no effect of HT on HRV (Niskanen et al., 2002; Virtanen et al., 2000) or even a decrease in both linear and non-linear HRV (Christ et al., 1999; Lantto et al., 2012; Virtanen et al., 2008) . Decreased vagal HRV is associated with increased cardiovascular mortality (Huikuri and Stein, 2013) . In the Women's Health Initiative study, HT in older women increased the risk of HF, high-frequency; REM, rapid eye movement; SD2, long-term R-R interval variability coefficient; SDNN, standard deviation of R-R intervals; SEn, spectral entropy. Significant correlations: *P < 0.05; **P < 0.01.
ª 2017 European Sleep Research Society cardiovascular mortality (Hodis and Mack, 2014) . In a subset analysis of the same study, decreased vagal cardiac function associated with increased overall mortality (Gorodeski et al., 2011) , which implies that autonomic nervous system function may in part account for the changes in mortality with HT use.
There are some limitations in our study. First, we recruited only healthy women; therefore, we cannot extrapolate our results to women with chronic diseases. Second, although women with previous diagnosis of sleep apnea and restless legs syndrome were excluded, we did not include leg electrodes or nasal pressure transducers in the polysomnography, and oximetry data were lacking in young women. However, the likelihood for sleep-disordered breathing was small among the young women. Furthermore, as the omission of women with ODI4 greater than 15 per h did not change the results, sleep-disordered breathing unlikely affected the results. Third, we evaluated subjective symptomatology only once and included the latest 6 months, so the possible HRV effects of changes in symptomaticity between nights cannot be excluded. Fourth, HT use in our study does not meet present recommendations, as the women on HT were mostly 10 years postmenopausal. However, the patients were recruited prior to the publication of the Women's Health Initiative (Hodis and Mack, 2014) study results, and therefore our design met the criteria of its time. Fifth, as the young women used oral contraceptives, our results may not be generalizable to all young women, as without hormonal contraception there are clear-cut changes in HRV patterns across the menstrual cycle, while on oral contraception no clear cyclic changes in HRV can be seen (Teixeira et al., 2015) . Last, our patient groups were small and uneven, which limits the possibilities to detect group differences. The small group sizes also led us to use combined groups in the correlation analyses. However, although there were significant group differences, these showed a higher amount of vagal dominance both in sleep and HRV parameters in the younger groups. This implied that group-wise, no significant conflict between the behaviour of the variables should be expected.
CONCLUSI ON S
A first night in a sleep laboratory seems to elicit a very mild effect on overnight cardiac autonomic function in women of different reproductive stages. This finding was irrespective of clear-cut differences in HRV between groups and changes in sleep architecture between nights. Only a slight decrease in vagally mediated non-linear HRV was found, and correlations between HRV variables and sleep parameters were weak and inconsistent. The small effect might attribute to simultaneous, divergent sleep architecture changes with partly vagal, partly sympathetic influence. The findings warrant further analyses in different sleep stages, but overall they imply that it is not only the quantity but also the quality of sleep that counts when evaluating the effects of disturbed sleep.
